Pharma company, supplement chain retailer weigh in on CBD during White House meetings

9/28/20–As the hemp industry awaits guidance from food and drug regulators on whether CBD will be permitted to be used as an ingredient in food and dietary supplements, the White House Office of Management and Budget continues to meet with companies and industry advocates to gain insight. Two of those meetings discussing the future of cannabidiol were with CBD drug maker GW Pharmaceuticals and chain retailer General Nutrition Centers (GNC). Read